Top 5 gainers and losers in the Midcap and Smallcap segment during this week!
5paisa Research Team
Last Updated: 13th December 2022 - 08:44 am
List of top 5 gainers and losers in the Midcap and Smallcap segments for the week from January 21 to 27, 2022.
The hawkish stance by the US Fed sent the markets world over in jitters, and Indian markets tumbled shedding 2187 points or 3.68% to close at 57276.94 as investors dumped risky assets amid rising bond yields in US.
In the broader markets, the S&P BSE Midcap index closed at 23942.10 with a week’s loss of 5.98% in yesterday’s trading session much in tune with the benchmark indices. The midcap index touched a week’s low of 23490.16 under the shaky sentiments of the market participants. The S&P BSE Smallcap which logged a 52-week high of 31304.44 on January 18 shed 6.32% of its gains and closed at 28633.52 for the week.
Let us have a look at the top 5 gainers and losers in the Midcap space for this week:
|
Sharda Cropchem Ltd.
|
52.50
|
|
Punjab Alkalies & Chemicals Ltd.
|
31.98
|
|
Sadhana Nitro Chem Ltd.
|
15.51
|
|
Sukhjit Starch & Chemicals Ltd.
|
15.13
|
|
Vikas EcoTech Ltd.
|
14.74
|
The bull rally was led by Sharda Cropchem Ltd in the midcap segment. The shares of the company delivered a weekly return of 52.50%. The share price of the company rose from Rs 379.25 to Rs 578.35 during the period. The agrochemical company presented stellar Q3 results with a 78% jump in Consolidated Revenue from Operation of Rs 880 crore on YoY Basis while showing a 112% jump in Consolidated Net profit Rs 102 crore on YoY basis, driving the market sentiment in its favour in contrast to the heavy meltdown in benchmark indices. The stock logged its 52-week high in yesterday’s trading session at Rs 578.35 which is also its all-time high.
The top 5 losers from the Midcap segment for this week are as follows:
|
RateGain Travel Technologies Ltd.
|
-15.31
|
|
Raghuvir Synthetics Ltd.
|
-14.24
|
|
Vikas Lifecare Ltd.
|
-14.05
|
|
Urja Global Ltd.
|
-14.02
|
|
Syncom Formulations (India) Ltd.
|
-14.00
|
The laggards of the midcap segment were led by RateGain Travel Technologies Ltd. The shares of the company fell 15.31% from Rs 431.55 to Rs 365.50. The company which is India’s largest SaaS provider in the hospitality and travel industry succumbed to selling pressures after logging its all-time high at Rs 525 on January 18, falling by 30% from its high to close at Rs 365.45 for the week. The stock made a weak debut at the exchanges on December 17, listing at a discount of 15% to its issue price. The stock came under the bear radar as high P/E stocks received a backlash at the markets this week.
Let us move towards the top 5 gainers and losers in the Smallcap segment:
The top 5 gainers in the Smallcap segment for this week are as follows:
|
Vanta Bioscience Ltd.
|
44.98
|
|
Variman Global Enterprises Ltd.
|
32.97
|
|
Pressman Advertising Ltd.
|
21.45
|
|
Shanti Educational Initiatives Ltd.
|
15.74
|
|
Ruttonsha International Rectifier Ltd.
|
15.74
|
The top gainer in the Smallcap segment was Vanta Bioscience Ltd. The stock surged 44.98% for the week. Share price of the company rose from Rs 114.50 to Rs 166 during the period. The stock has rallied 14.3% on yesterday’s trading session and 20% on the day before. The stock sailed against the bear current that prevailed over the market and gained 34.3% in just two trading sessions.
The top 5 losers in the Smallcap segment for this week are as follows:
|
Samrat Pharmachem Ltd.
|
-20.47
|
|
Paramone Concepts Ltd.
|
-20.21
|
|
Sat Industries Ltd.
|
-19.32
|
|
Tinna Rubber And Infrastructure Ltd.
|
-14.25
|
|
Orissa Bengal Carrier Ltd.
|
-14.24
|
The losers of smallcap space were led by Samrat Pharmachem Ltd. The shares of the company fell from Rs 510.45 to Rs 405.95 registering a loss of 20.47 per cent in the stock price by trading in the red territory for the entire week after logging its all-time high of Rs 578 on January 17.
- Flat ₹20 Brokerage
- Next-gen Trading
- Advance Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.